Vol. 1 No. 1 (2024), Articles
Vol. 1 No. 1 (2024)

HIV/AIDS

Articles
Published 2025-03-14
Jumanova Nargiza Eshmamatovna
Master teacher at Samarkand State Medical University
Tursunmurodov Rustam Ravshan o’g’li
Student of Samarkand State Medical University
PDF

Keywords

HIV, AIDS, vaccine development, public health. , immune system, antiretroviral therapy (ART), CD4 cells, viral load, opportunistic infections, HIV transmission, prevention strategies, PrEP, PEP, HIV vaccine research, stigma and discrimination, HIV and mental health, global HIV epidemic, co-infections, mother-to-child transmission, U=U (Undetectable = Untransmittable).

Abstract

HIV/AIDS remains one of the most significant global health challenges, affecting millions worldwide. Advances in medical research have transformed HIV from a fatal disease into a manageable chronic condition. This article explores the virology of HIV, the progression to AIDS, current treatment strategies, and the latest developments in prevention and vaccine research. Emerging therapeutic approaches and public health strategies are also discussed. HIV is a major global health concern that weakens the immune system and increases vulnerability to infections and diseases. Despite advances in antiretroviral therapy (ART), challenges such as stigma, treatment access, and co-infections persist. This article explores HIV transmission, the impact on the immune system, current treatment strategies, preventive measures like PrEP and PEP, and ongoing research into vaccines and potential cures. The fight against HIV requires a combination of medical innovation, public health initiatives, and social awareness to reduce infections and improve the lives of people living with the virus.

PDF

References

1. Fauci AS, Lane HC. HIV/AIDS: much accomplished, much to do. Science. 2020; 370(6518): 916-921.

2. Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1(1):15035.

3. UNAIDS. Global HIV & AIDS statistics—Fact sheet 2023. Available at: www.unaids.org

4. Barouch DH. Novel vaccine strategies for HIV-1. Nat Med. 2018; 24(11): 1564-1573.

5. Collins FS, Marston HD. HIV/AIDS research: new opportunities for progress. JAMA. 2017;318(17):1651-1652.

6. Tebas P, Jadlowsky J, Shaw PA, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014; 370(10): 901-910.

7. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373(6510):123-126.

8. Cohen, J. (2001). Shots in the Dark: The Wayward Search for an AIDS Vaccine. W.W. Norton & Company.

9. Shultz, J. M., & Gabriel, M. A. (2012). Handbook of HIV Prevention. Springer.

10. Iliffe, J. (2007). The African AIDS Epidemic: A History. Ohio University Press.

11. Gallo, R. C. (2006). Virus Hunting: AIDS, Cancer, and the Human Retrovirus. Basic Books.